These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 15362179)
1. A comparison of the EQ-5D and SF-6D across seven patient groups. Brazier J; Roberts J; Tsuchiya A; Busschbach J Health Econ; 2004 Sep; 13(9):873-84. PubMed ID: 15362179 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement. Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466 [TBL] [Abstract][Full Text] [Related]
3. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia. McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564 [TBL] [Abstract][Full Text] [Related]
4. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Petrou S; Hockley C Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981 [TBL] [Abstract][Full Text] [Related]
5. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises. Whitehurst DG; Norman R; Brazier JE; Viney R Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050 [TBL] [Abstract][Full Text] [Related]
6. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688 [TBL] [Abstract][Full Text] [Related]
7. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452 [TBL] [Abstract][Full Text] [Related]
8. Interchangeability of the EQ-5D and the SF-6D in long-lasting low back pain. Søgaard R; Christensen FB; Videbaek TS; Bünger C; Christiansen T Value Health; 2009 Jun; 12(4):606-12. PubMed ID: 19900258 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 years. Barton GR; Sach TH; Avery AJ; Jenkinson C; Doherty M; Whynes DK; Muir KR Health Econ; 2008 Jul; 17(7):815-32. PubMed ID: 17893863 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort. Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054 [TBL] [Abstract][Full Text] [Related]
11. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis. Lillegraven S; Kristiansen IS; Kvien TK Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285 [TBL] [Abstract][Full Text] [Related]
12. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III. Maes IH; Joore MA; Cima RF; Vlaeyen JW; Anteunis LJ Ear Hear; 2011; 32(4):428-35. PubMed ID: 21221004 [TBL] [Abstract][Full Text] [Related]
13. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients. Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540 [TBL] [Abstract][Full Text] [Related]
14. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD). Gerhards SA; Huibers MJ; Theunissen KA; de Graaf LE; Widdershoven GA; Evers SM Value Health; 2011; 14(5):732-9. PubMed ID: 21839412 [TBL] [Abstract][Full Text] [Related]
15. A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD). Chen J; Wong CK; McGhee SM; Pang PK; Yu WC PLoS One; 2014; 9(11):e112389. PubMed ID: 25379673 [TBL] [Abstract][Full Text] [Related]
16. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D. Hawton A; Green C; Telford C; Zajicek J; Wright D Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811 [TBL] [Abstract][Full Text] [Related]
17. [The burden of depressive disorders in Germany - results from the European Study of the Epidemiology of Mental Disorders (ESEMeD)]. Günther OH; Friemel S; Bernert S; Matschinger H; Angermeyer MC; König HH Psychiatr Prax; 2007 Sep; 34(6):292-301. PubMed ID: 17806016 [TBL] [Abstract][Full Text] [Related]
18. EQ-5D versus SF-12 in coronary patients: are they interchangeable? De Smedt D; Clays E; Annemans L; De Bacquer D Value Health; 2014; 17(1):84-9. PubMed ID: 24438721 [TBL] [Abstract][Full Text] [Related]
19. Quality-adjusted life expectancies in patients with rheumatoid arthritis--comparison of index scores from EQ-5D, 15D, and SF-6D. Sørensen J; Linde L; Ostergaard M; Hetland ML Value Health; 2012; 15(2):334-9. PubMed ID: 22433765 [TBL] [Abstract][Full Text] [Related]
20. The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning. Günther O; Roick C; Angermeyer MC; König HH Drug Alcohol Depend; 2007 Jan; 86(2-3):253-64. PubMed ID: 16930855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]